title: alpha1-Antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia.
abstract: alpha1-Antitrypsin (AAT) circulates in high serum concentrations, and impregnates most body tissues. AAT has a broad anti-inflammatory spectrum, and modulates most inflammatory reactions occurring in human body. Recently, a possible relationship between AAT deficiency (AAT-D) and fibromyalgia (FM) has been raised, with the finding that intravenous infusions of purified human AAT efficiently controlled FM symptoms in two patients with severe hereditary AAT-D. On the other hand, functional magnetic resonance imaging has detected a significant greater activity in pain sensitive areas of the brain in patients with FM, in response to cutaneous stimuli, providing further evidence for a physiological explanation for FM pain. In recent studies abnormal profiles of inflammation markers in serum and biopsies have been found in FM patients. Since most of these inflammation mediators can be inhibited by AAT, these observations would suggest that at least a subset of the FM syndrome could be related to an inflammatory process, possibly due to an imbalance between inflammatory and anti-inflammatory substances, in the soft body tissues. Future directions of research would be: (1) to develop epidemiological studies to determine the gene frequency of AAT deficiency alleles in FM patients; (2) implementation of a double-blind placebo-controlled clinical trial to determine the specific role of AAT augmentation therapy in AAT-D patients with FM; (3) identification of specific laboratory markers for diagnostic and clinical evaluation purposes in FM; (4) application of the newest medical imaging techniques for diagnosis; and (5) identification of genetic, familial, and environmental risk factors suspected to participate in the FM syndrome development.
authors.affiliation: Department of Internal Medicine, Hospital Valle del Nalón, 33920 Riaño-Langreo, Principado de Asturias, Spain. ignacio.blanco@sespa.princast.es
authors.forename: Lgnacio Eduardo
authors.initials: LE
authors.lastname: Blanco
authors.forename: Frederick Joseph
authors.initials: FJ
authors.lastname: de Serres
authors.forename: Enrique
authors.initials: E
authors.lastname: Fernańdez-Bustillo
authors.forename: Daniel Al
authors.initials: DA
authors.lastname: Kassam
authors.forename: Daniel
authors.initials: D
authors.lastname: Arbesú
authors.forename: Carmen
authors.initials: C
authors.lastname: Rodríguez
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Torre
mesh_terms: D005356:Fibromyalgia / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D006801:Humans; D000515:alpha 1-Antitrypsin / Q000502:physiology* / Q000627:therapeutic use
chemical_list: D000515:alpha 1-Antitrypsin